The recent challenges in global supply have highlighted the value of securing essential medications like Ivermectin. Trusting on overseas manufacturers exposes countries to considerable vulnerabilities, including shipping delays, cost fluctuations, and even geopolitical threats. Shifting towards domestic production of Ivermectin offers a multitude